Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).

Emerging
growth company o

If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 8.01

Other Events.

Due to the impact of the COVID-19 coronavirus pandemic on the
business, employees, consultants and service providers of Scworx, Corp., a Delaware corporation (the “Company”), the
Company is unable to file its annual report on Form 10-K for the year ended December 31, 2019 (the “Annual Report”)
by the normally prescribed deadline of March 30, 2020. The Company plans to file its Annual Report by no later than May 14, 2020,
45 days after the original due date of its Annual Report, in reliance upon the exemption set forth in the Securities and Exchange
Commission’s March 4, 2020 Order (Release No. 34-88318) (the “Order”), which under certain conditions exempts
reporting companies form making certain filings required under the Securities and Exchange Act of 1934, as amended, for up to 45
after the normally prescribed deadline.

The Company’s operations and business have experienced
disruption due to the unprecedented conditions surrounding the COVID-19 pandemic spreading throughout the United States and the
world. The New York and New Jersey area, where the Company and its independent auditor are headquartered, is currently at one of
the epicenters of the coronavirus outbreak in the United States. The Company has been following the recommendations of local health
authorities to minimize exposure risk for its team members for the past several weeks, including the temporary closures of its
offices and having team members work remotely, and, as a result, the Annual Report will not be completed by the filing deadline,
due to insufficient time to facilitate the internal and external review process.

In addition, the Company’s customers (hospitals) have
also experienced extraordinary disruptions to their businesses and supply chains, while experiencing unprecedented demand for health
care services related to COVID-19. As a result of these extraordinary disruptions to our customers’ business, our customers
are currently focused on meeting the nation’s health care needs in response to the COVID-19 pandemic. As a result, there
is a risk that our customers will not be able to focus any resources on expanding the utilization of our services, which could
adversely impact our future growth prospects, at least until the adverse effects of the pandemic subside. In addition, the financial
impact of COVID-19 on our hospital customers could cause the hospital to delay payments due to us for services, which could negatively
impact our cash flows. We are endeavoring to mitigate these risks through the sale of personal protective equipment (“PPE”)
to the health care industry, including many of our hospital customers. This is a new business for us and there is no assurance
that we will be able to complete any sales of PPE or that any such sales will be sufficient to offset the negative effects of the
COVID-19 pandemic on our business.

1

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.